课题基金 / 基金详情

Painimation: An innovative, technology-based method for measuring pain quality, location and severity in sickle cell disease

Painimation: An innovative, technology-based method for measuring pain quality, location and severity in sickle cell disease
Painimation:一种基于技术的创新方法,用于测量镰状细胞病的疼痛质量、位置和严重程度
批准号:
9649363
负责人:
Charles Richard Jonassaint
金额:
$7.83万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-15 至 2020-08-31

项目摘要

项目成果

Charles Richard Jonassaint的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 疼痛是患有镰状细胞病(SCD)的成年人获得医疗保健系统的头号原因。至 充分治疗疼痛首先需要准确的评估,然而,目前还没有有效的疼痛措施 捕捉SCD疼痛的多维现象。对疼痛的一维测量,例如 数值型0-10分,实用性有限,对指导治疗无效。多维止痛工具 既长又复杂,使患者很难使用。还没有人试图创建一个多- 对SCD疼痛进行评估和分类的维度测量。这个项目的长期目标是开发一种 全面的、以患者为中心的疼痛评估工具,将改善患者与提供商之间的沟通, 疼痛的诊断和治疗。建议的R03测试一种新的电子疼痛评估工具 Painimation,允许患者使用动画和图形图像来传达他们的痛苦。我们的 主要目标将是确定Painimation是否为患者所接受并可用作有效的SCD 疼痛评估工具。我们假设Painimation比Painimation更有用,更容易被患者接受 标准刻度。在目标1中,我们将确定绘画用于沟通的可用性和可接受性 以及评估患有SCD的成年人的疼痛。我们将测试Painimation和其他经过验证的疼痛等级( 0-10视觉模拟评分、PainDETECT和McGill疼痛问卷)对70名成年SCD患者进行了调查 横断面调查研究。对于每一项测量,我们将评估可用性、患者满意度和感知 向提供者传达痛苦的有用之处。在目标2中,我们将确定是否使用 画龙点睛与患者的生活质量和临床结局有关。我们将测试它们之间的关联 患者报告的生活质量(ASCQ-Me)和客观健康结果(即器官损害, 疼痛的急性护理访问次数),以确定止痛是否是临床试验中可行的结果衡量标准 测试疼痛干预措施。最后,在探索性目标3中,我们将测试Painimation是否可以区分 SCD疼痛类型(例如神经病理性与伤害性)。这项拟议的研究意义重大,因为它将导致 创建用于SCD的简短、准确且以用户为中心的疼痛评估工具。我们的团队包括 IT、UX设计、PIN和测量开发方面的专家。扩展绘画,一种新颖的技术-- 基于疼痛评估工具,在SCD中使用,直接与我的K23项目相关并产生结果,将 发挥我作为独立调查员的潜力,进行大规模研究(R01),研究 疼痛干预对健康结果的影响。长期的、改进的结果衡量标准将增加 我们能够检测移动技术提供的行为干预的影响。
英文摘要
PROJECT ABSTRACT Pain is the number one reason adults with sickle cell disease (SCD) access the healthcare system. To adequately treat pain first requires accurate assessment, however, there are no pain measures that effectively capture the multidimensional phenomenon of SCD pain. One-dimensional measures of pain, such as the numerical 0-10 scale, have limited utility and are ineffective for guiding treatment. Multi-dimensional pain tools are long and complex, making them difficult for patients to use. There have been no attempts to create a multi- dimensional measure to assess and classify pain in SCD. The long-term goal of this project is to develop a comprehensive, patient-centered, pain assessment tool, that will improve patient-provider communication, pain diagnosis, and treatment of pain. The proposed R03 tests a novel electronic pain assessment tool called Painimation, that allows patients to use animations and graphical images to communicate their pain. Our primary objective will be to determine if Painimation is acceptable to patients and can be used as a valid SCD pain assessment tool. We hypothesize that Painimation will be more usable and acceptable to patients than standard scales. In Aim 1, we will determine the usability and acceptability of Painimation for communicating and assessing pain among adults with SCD. We will test Painimation alongside other validated pain scales (the 0-10 visual analog scale, PainDETECT, and the McGill Pain Questionnaire) among 70 adults with SCD in a cross-sectional survey study. For each measure, we will evaluate usability, patient satisfaction, and perceived usefulness for communicating pain to providers. In Aim 2, we will determine whether pain assessment using Painimation is associated with patients' quality of life and clinical outcomes. We will test the association of Painimation with patient-reported quality of life (ASCQ-Me) and objective health outcomes (i.e. organ damage, number of acute care visits for pain) to determine if Painimation is a viable outcome measure in clinical trials testing pain interventions. Finally, in an exploratory Aim 3, we will test whether Painimation can differentiate SCD pain types (e.g. neuropathic vs nociceptive). The proposed research is significant because it will lead to the creation of a brief, accurate, and user-centered pain assessment tool for use in SCD. Our team includes experts in IT, UX design, pain, and measurement development. Expanding Painimation, a novel, technology- based pain assessment tool, for use in SCD directly relates to and results from my K23 project and will advance my potential as an independent investigator to conduct large-scale (R01) studies examining the impact of pain interventions on health outcomes. Long-term, improved outcomes measurement will increase our ability to detect the effects of our mobile technology-delivered behavioral interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Designing an Implementation Strategy for Delivering Routine Mental Health Screening and Treatment for Adolescents and Adults with Sickle Cell Disease
Geospatial and Ecological momentary assessment Technology and Activity Engagement for at-risk youth
Geospatial and Ecological momentary assessment Technology and Activity Engagement for at-risk youth
Using Technology to Deliver Evidence-Based Interventions for Pain to Patients with Sickle Cell Disease
海外基金